Dozens of African countries unlikely to meet goals for HIV testing, condom use

Dozens of African countries have made limited progress and are unlikely to meet UNAIDS targets for HIV testing and condom use by 2030, researchers reported at the HIV Research for Prevention virtual conference.

Phuong Nguyen, a PhD candidate at St. Luke’s International University Graduate School of Public Health in Tokyo, and colleagues assessed survey data from more than 1.4 million sexually active individuals aged between 15 and 49 years in 38 African countries from 2003 to 2018 and used modeling to estimate what the prevalence of annual HIV testing and condom use will be for every country and year through 2030. The UNIADS target is 95% coverage for both.

“Condom use and HIV testing are the key paths of treatment as prevention strategies, and I actually think [hitting the] targets for these strategies is essential to eliminate HIV in Africa,” Nguyen said during a press conference.

Indeed, a UNAIDS report published last year said condoms “remain a cornerstone of effective prevention programming,” but that investments and programming for condoms “remain suboptimal.”

Scroll to Top

During the Canada Post strike announced September 25, 2025, the following measures will be undertaken to minimize service disruption to BC-CfE clients and providers.

  • The BC-CfE Laboratory has transitioned to private courier for delivery of outgoing reports and documents. Results required urgently can be faxed upon request. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
  • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office. (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
  • St. Paul’s Hospital Ambulatory Pharmacy has transitioned to private courier for delivery of medications. We recommend requesting medication at least 2 weeks in advance in case of delivery delays, particularly to rural/remote parts of BC. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)

During the Canada Post strike, we recommend that documents be faxed or couriered to our sites, versus utilization of regular mail service

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below